IDEXX Laboratories, Inc.
IDXX
$556.93
$11.072.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 15.62% | 22.38% | 19.33% | 18.61% | 16.56% |
| Total Depreciation and Amortization | 11.92% | 10.97% | 11.73% | 11.27% | 13.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 211.02% | 329.56% | 360.60% | 2,279.19% | 510.04% |
| Change in Net Operating Assets | 48.51% | -128.05% | -70.76% | -206.27% | -3,040.76% |
| Cash from Operations | 51.41% | 24.96% | 27.21% | 18.68% | -6.54% |
| Capital Expenditure | 3.53% | -4.94% | -3.10% | -0.22% | 6.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.40% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.11% | -44.66% | -22.41% | -818.82% | -201.97% |
| Cash from Investing | -1.22% | -8.05% | 34.20% | 25.15% | 34.16% |
| Total Debt Issued | -42.25% | 562.59% | -- | -- | -- |
| Total Debt Repaid | -82.19% | -471.18% | -471.18% | 31.08% | -104.52% |
| Issuance of Common Stock | 180.34% | 238.67% | 109.84% | 108.49% | -14.77% |
| Repurchase of Common Stock | 2.17% | -8.18% | -44.44% | -93.03% | -167.93% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -18.23% | 1.71% | -32.67% | -39.47% | -104.27% |
| Foreign Exchange rate Adjustments | -120.38% | 263.13% | 217.52% | -70.30% | 336.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.65% | 115.66% | 34.69% | -335.69% | -188.18% |